SCHEMBL25241237

SCHEMBL25241237

O=C(Cl)C(=O)c1c[nH]c2ccc(F)c(F)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.47
▸ CES2 O00748 2/20 0.39
▸ CES1 P23141 2/20 0.39
▸ F7 P08709 1/20 0.38
▸ F3 P13726 1/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ HTR6 P50406 2/20 0.38
▸ HTR7 P34969 2/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ PRKAB2 O43741 2/20 0.35
▸ PRKAG1 P54619 2/20 0.35
▸ PRKAA2 P54646 2/20 0.35
▸ PRKAA1 Q13131 2/20 0.35
▸ PRKAG3 Q9UGI9 2/20 0.35
▸ PRKAG2 Q9UGJ0 2/20 0.35
▸ PRKAB1 Q9Y478 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25423742 0.82 HTR1A (0.48) HTR6HTR7HTR1APRKAB2PRKAG1
SCHEMBL16597465 0.81 GPR84 (0.51) GPR84F7F3HTR2AHTR6
SCHEMBL1732171 0.81 HTR2A (0.47) GPR84CES2CES1HTR2ABCHE
SCHEMBL25748755 0.77 GPR84 (0.41) GPR84CES2CES1HTR2AHTR6
SCHEMBL25748750 0.77 GPR84 (0.44) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25748801 0.77 TNF (0.37) CES2CES1HTR1A
SCHEMBL25435471 0.76 GPR84 (0.43) GPR84HTR2AHTR6HTR7HTR1A
SCHEMBL25423216 0.76 GPR84 (0.40) GPR84CES2CES1HTR2AHTR6
SCHEMBL25423716 0.74 CES2 (0.38) CES2CES1F7F3HTR1A
SCHEMBL25423230 0.74 CES2 (0.39) CES2CES1BCHENR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB GPR84 3280/4885CES2 27/4885CES1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback